Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy
Mentore Ribolsi,Lorenzo Marchetti,Lucrezia Maria Olmi,Michele Cicala,Edoardo Savarino
DOI: https://doi.org/10.1111/nmo.14953
2024-11-03
Neurogastroenterology & Motility
Abstract:The present study reinforces the usefulness of an accurate clinical and functional evaluation of patients with esophageal symptoms, carried out by both impedance‐pH monitoring and high‐resolution manometry, allowing to discriminate particular characteristics in patients with dominant heartburn, noncardiac chest pain, and regurgitation, which may benefit of distinct therapeutic strategies. Background Gastro‐esophageal reflux disease (GERD) is the most common cause for noncardiac chest pain (NCCP), with an estimated prevalence rate ranging between 30% and 60%. Heartburn and NCCP may share common mechanisms. Aims/Methods To assess whether particular patterns of impedance‐pH variables characterize patients with dominant heartburn, regurgitation, or NCCP and their ability to predict proton pump inhibitor (PPI) response for each symptom, GERD patients, evaluated with high‐resolution manometry (HRM) and impedance‐pH, were included. Results In total, 109 NCCP, 68 heartburn, and 64 regurgitation patients were included. Pathological reflux episodes were observed in 28%, 19%, and 56% (p 80 refluxes and type 2/3 esophagogastric junction (EGJ) were associated with regurgitation perception (OR: 0.31, 95% CI: 0.16–0.59; p 80 to PPI refractoriness. Conclusions We highlight the usefulness of an accurate clinical and functional evaluation of GERD patients, allowing to discriminate particular characteristics in patients with dominant heartburn, NCCP, or regurgitation, which may benefit of distinct therapeutic strategies.
gastroenterology & hepatology,neurosciences,clinical neurology